Operating Lease, Right-of-Use Asset of Viracta Therapeutics, Inc. from 31 Mar 2019 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Viracta Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2024.
  • Viracta Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2024 was $0, a 100% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Viracta Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $0 -$371,000 -100% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 $71,000 -$390,000 -85% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $175,000 -$377,000 -68% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $274,000 +$8,000 +3% 31 Dec 2023 10-Q 13 Nov 2024 2024 Q3
Q3 2023 $371,000 +$9,000 +2.5% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $461,000 +$5,000 +1.1% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $552,000 +$3,000 +0.55% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $266,000 -$374,000 -58% 31 Dec 2022 10-K 07 Mar 2024 2023 FY
Q3 2022 $362,000 -$367,000 -50% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $456,000 -$360,000 -44% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $549,000 -$489,000 -47% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $640,000 -$346,000 -35% 31 Dec 2021 10-K 14 Mar 2023 2022 FY
Q3 2021 $729,000 +$320,000 +78% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $816,000 +$271,000 +50% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $1,038,000 +$357,000 +52% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 $986,000 +$870,511 +754% 31 Dec 2020 10-K 17 Mar 2022 2021 FY
Q3 2020 $409,000 -$545,000 -57% 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 $545,000 -$545,000 -50% 30 Jun 2020 10-Q 11 Aug 2020 2020 Q2
Q1 2020 $681,000 -$545,000 -44% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $115,489 31 Dec 2019 8-K/A 23 Mar 2021
Q3 2019 $954,000 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $1,090,000 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $1,226,000 31 Mar 2019 10-Q 08 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.